Zeolite (Clinoptilolite)

Updated June 29, 2026

Zeolites are naturally occurring aluminosilicate minerals formed from volcanic ash and seawater over millions of years. Their defining feature is a rigid, highly porous cage-like crystal structure with negatively charged internal channels of a specific size — roughly 0.4 nanometres for clinoptilolite, the most studied form for human use. This structure allows zeolite to function as a molecular sieve, selectively trapping positively charged molecules and ions that fit within the channels while leaving larger molecules unaffected. In the gut, this means it can selectively adsorb heavy metal ions (lead, mercury, cadmium, arsenic), ammonium (relevant for liver disease and gut dysbiosis), and certain mycotoxins.

The heavy metal binding capacity is the most scientifically interesting property. Unlike activated charcoal which binds everything indiscriminately, clinoptilolite has preferential affinity for lead and ammonium over calcium and magnesium — meaning it can theoretically bind toxic metals without depleting essential minerals at the same rate. Several human pilot studies have shown measurable reductions in urinary heavy metal excretion after zeolite supplementation, suggesting systemic metal mobilisation. Animal studies support reduced tissue accumulation of lead and mercury with zeolite co-supplementation.

A meaningful body of research from Croatia and Central Europe — where zeolite deposits are abundant and research has been ongoing for decades — documents anti-inflammatory effects, improved gut barrier function (reduced intestinal permeability), and antioxidant activity. One well-cited clinical study found that athletes taking micronised clinoptilolite had significantly reduced markers of intestinal permeability compared to placebo. The proposed mechanism is that zeolite physically adsorbs luminal toxins that would otherwise trigger gut inflammation, and may directly interact with intestinal tight junction proteins.

Safety is generally regarded as good. Clinoptilolite is not absorbed into the bloodstream — it transits the gut and exits in stool, taking its bound contents with it. It has GRAS (Generally Recognised As Safe) status in the US for certain applications. Like all binders it should be taken away from medications and other supplements. Micronised forms (particle size under 5 microns) are considered more effective than coarser powders for intestinal binding. Standard doses in research protocols range from 1.8 to 3.6 g daily in divided doses. This is general information, not medical advice.